Skip to main content

Gel Co., Axaron Bioscience, Spotfire


Gel Co. of San Francisco last week announced the ArrayBooster, a low-volume hybridization station for DNA and protein microarrays. The system is compatible with slide-based microarrays and has an active agitation feature based on surface acoustic waves. The product uses Advacards, a micro-agitation card with integrated pumps that cover the array and minimize the required sample volume. The company says the product will reduce incubation times and increase the specificity of hybridization and is suitable for the detection of low-expression genes. The product holds four incubation chambers that are controlled by one personal computer.


Axaron Bioscience launched Axaminer, a research and development service for drug discovery. Axaminer enables gene expression profiling at a cellular level and allows a detailed analysis of isolated cells. The Axaminer technology comprises four integrated modules: specific cell labeling; automated cell isolation using laser microdissection technology; isolation and amplification of picogram amounts of RNA; and transcription profiling.


Spotfire has released a new version of DecisionSite, with Analysis Builder, a tool for visual and interactive data analysis, and Poster, a collaboration tool.


The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.